approached significanceP = 0.05
24 However, the difference in thromboembolic events approached significance with increasing TXA dosage (placebo: 12.0%; 2 g: 26.5%; 4 g: 32.0%; P = 0.05). 24 Systematic Review of In-Hospital Use of TXA in TBI The CRASH-3 study examined the effect of TXA on TBI death in 9,127 patients randomly assigned to receive treatment or placebo within 3 hours of injury.